137 related articles for article (PubMed ID: 28383568)
1. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.
Yan X; Zhu Z; Xu S; Yang LN; Liao XH; Zheng M; Yang D; Wang J; Chen D; Wang L; Liu X; Liu J; Chen RH; Zhou XZ; Lu KP; Liu H
Sci Rep; 2017 Apr; 7():45915. PubMed ID: 28383568
[TBL] [Abstract][Full Text] [Related]
2. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.
Wang Y; Sun B; Zhao X; Zhao N; Sun R; Zhu D; Zhang Y; Li Y; Gu Q; Dong X; Wang M; An J
Oncotarget; 2016 Apr; 7(17):24383-401. PubMed ID: 27027434
[TBL] [Abstract][Full Text] [Related]
3. FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.
Liu LL; Lu SX; Li M; Li LZ; Fu J; Hu W; Yang YZ; Luo RZ; Zhang CZ; Yun JP
Oncotarget; 2014 Jul; 5(13):5113-24. PubMed ID: 24970808
[TBL] [Abstract][Full Text] [Related]
4. HuR facilitates miR-93-5p-induced activation of MAP3K2 translation via MAP3K2 3'UTR ARE2 in hepatocellular carcinoma.
Shi X; Qi Z; Huang D; Zhu J; Shen X; Liu T
Biochem Biophys Res Commun; 2024 Aug; 722():150152. PubMed ID: 38795452
[TBL] [Abstract][Full Text] [Related]
5. Understanding the role of PIN1 in hepatocellular carcinoma.
Cheng CW; Leong KW; Tse E
World J Gastroenterol; 2016 Dec; 22(45):9921-9932. PubMed ID: 28018099
[TBL] [Abstract][Full Text] [Related]
6. A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways.
Yang D; Luo W; Wang J; Zheng M; Liao XH; Zhang N; Lu W; Wang L; Chen AZ; Wu WG; Liu H; Wang SB; Zhou XZ; Lu KP
J Control Release; 2018 Jan; 269():405-422. PubMed ID: 29170140
[TBL] [Abstract][Full Text] [Related]
7. Interactome analysis of gene expression profiles identifies CDC6 as a potential therapeutic target modified by miR-215-5p in hepatocellular carcinoma.
Xu H; Huang J; Hua S; Liang L; He X; Zhan M; Lu L; Chu J
Int J Med Sci; 2020; 17(18):2926-2940. PubMed ID: 33173413
[No Abstract] [Full Text] [Related]
8. The miR-92a-2-5p in exosomes from macrophages increases liver cancer cells invasion via altering the AR/PHLPP/p-AKT/β-catenin signaling.
Liu G; Ouyang X; Sun Y; Xiao Y; You B; Gao Y; Yeh S; Li Y; Chang C
Cell Death Differ; 2020 Dec; 27(12):3258-3272. PubMed ID: 32587378
[TBL] [Abstract][Full Text] [Related]
9. Pin1 facilitates NF-κB activation and promotes tumour progression in human hepatocellular carcinoma.
Shinoda K; Kuboki S; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Miyazaki M
Br J Cancer; 2015 Nov; 113(9):1323-31. PubMed ID: 26461058
[TBL] [Abstract][Full Text] [Related]
10. PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers.
Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP
Mol Cancer Ther; 2020 Mar; 19(3):906-919. PubMed ID: 31879364
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.
Liao P; Zeng SX; Zhou X; Chen T; Zhou F; Cao B; Jung JH; Del Sal G; Luo S; Lu H
Mol Cell; 2017 Dec; 68(6):1134-1146.e6. PubMed ID: 29225033
[TBL] [Abstract][Full Text] [Related]
12. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer.
Wei S; Kozono S; Kats L; Nechama M; Li W; Guarnerio J; Luo M; You MH; Yao Y; Kondo A; Hu H; Bozkurt G; Moerke NJ; Cao S; Reschke M; Chen CH; Rego EM; Lo-Coco F; Cantley LC; Lee TH; Wu H; Zhang Y; Pandolfi PP; Zhou XZ; Lu KP
Nat Med; 2015 May; 21(5):457-66. PubMed ID: 25849135
[TBL] [Abstract][Full Text] [Related]
13. Human MiR-544a Modulates SELK Expression in Hepatocarcinoma Cell Lines.
Potenza N; Castiello F; Panella M; Colonna G; Ciliberto G; Russo A; Costantini S
PLoS One; 2016; 11(6):e0156908. PubMed ID: 27275761
[TBL] [Abstract][Full Text] [Related]
14. miR-346 and miR-138 competitively regulate hTERT in GRSF1- and AGO2-dependent manners, respectively.
Song G; Wang R; Guo J; Liu X; Wang F; Qi Y; Wan H; Liu M; Li X; Tang H
Sci Rep; 2015 Oct; 5():15793. PubMed ID: 26507454
[TBL] [Abstract][Full Text] [Related]
15. Molecular crosstalk between cancer and neurodegenerative diseases.
Seo J; Park M
Cell Mol Life Sci; 2020 Jul; 77(14):2659-2680. PubMed ID: 31884567
[TBL] [Abstract][Full Text] [Related]
16. Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progression.
Frontiers Editorial Office
Front Oncol; 2024; 14():1388383. PubMed ID: 38505586
[TBL] [Abstract][Full Text] [Related]
17. Correction: Pin1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers.
Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP
Mol Cancer Ther; 2024 May; 23(5):743. PubMed ID: 38693904
[No Abstract] [Full Text] [Related]
18. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.
Zheng M; Xu H; Liao XH; Chen CP; Zhang AL; Lu W; Wang L; Yang D; Wang J; Liu H; Zhou XZ; Lu KP
Oncotarget; 2017 May; 8(18):29771-29784. PubMed ID: 28404959
[TBL] [Abstract][Full Text] [Related]
19. Identification of a potent and selective covalent Pin1 inhibitor.
Pinch BJ; Doctor ZM; Nabet B; Browne CM; Seo HS; Mohardt ML; Kozono S; Lian X; Manz TD; Chun Y; Kibe S; Zaidman D; Daitchman D; Yeoh ZC; Vangos NE; Geffken EA; Tan L; Ficarro SB; London N; Marto JA; Buratowski S; Dhe-Paganon S; Zhou XZ; Lu KP; Gray NS
Nat Chem Biol; 2020 Sep; 16(9):979-987. PubMed ID: 32483379
[TBL] [Abstract][Full Text] [Related]
20. Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells.
Kozono S; Lin YM; Seo HS; Pinch B; Lian X; Qiu C; Herbert MK; Chen CH; Tan L; Gao ZJ; Massefski W; Doctor ZM; Jackson BP; Chen Y; Dhe-Paganon S; Lu KP; Zhou XZ
Nat Commun; 2018 Aug; 9(1):3069. PubMed ID: 30093655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
